World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
33912
World Ranking
11233
National Ranking
5767

Beverly A. Teicher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Beverly A. Teicher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 620 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Beverly A. Teicher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Beverly A. Teicher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Beverly A. Teicher is affiliated with the National Institutes of Health in the United States and has a broad research portfolio primarily spanning medicine and biochemistry, genetics, and molecular biology.

Their published work includes significant contributions to the fields of oncology and cancer research, with a notable focus on molecular biology, pulmonary and respiratory medicine, and neurology. The scientist's research areas extend into subfields such as molecular biology, oncology, cancer research, pulmonary and respiratory medicine, and neurology.

Main topics addressed in their research include:

  • Cancer Genomics and Diagnostics
  • Neuroblastoma Research and Treatments
  • CAR-T Cell Therapy Research
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Sarcoma Diagnosis and Treatment

Frequent co-authors working alongside Beverly A. Teicher include James H. Doroshow, Malcolm A. Smith, Nathan P. Coussens, Thomas S. Dexheimer, and Stephen W. Erickson.

Beverly A. Teicher has contributed to several well-known publication venues, including:

  • Cancer Research
  • Molecular Cancer Therapeutics
  • Pediatric Blood & Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research Communications

Recent notable publications include:

  • "Cancer treatments: Past, present, and future," 2024, published in Cancer Genetics
  • "SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures," 2020, published in Cell Reports
  • "The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models," 2021, Clinical Cancer Research
  • "TGFβ-Directed Therapeutics: 2020," 2020, Pharmacology & Therapeutics
  • "Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets," 2020, Clinical Epigenetics

Best Publications

  • CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

    Beverly A. Teicher;Simon P. Fricker

  • Overexpression of metallothionein confers resistance to anticancer drugs.

    Susan L. Kelley;Alakananda Basu;Beverly A. Teicher;Miles P. Hacker

  • Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

    Junko Murai;Shar-yin N. Huang;Amèlie Renaud;Yiping Zhang

  • Classification of Antineoplastic Agents by their Selective Toxicities toward Oxygenated and Hypoxic Tumor Cells

    Beverly A. Teicher;John S. Lazo;Alan C. Sartorelli

  • Hypoxia and drug resistance

    Beverly A. Teicher

  • Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β

    Victoria C. Liu;Larry Y. Wong;Thomas Jang;Ali H. Shah

  • The proteasome inhibitor PS-341 in cancer therapy.

    Beverly A. Teicher;Gulshan Ara;Roy Herbst;Vito J. Palombella

  • Antibody-drug conjugates for cancer therapy.

    Anish Thomas;Beverly A Teicher;Raffit Hassan

  • A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

    K Antman;L Ayash;A Elias;C Wheeler

  • Antibody conjugate therapeutics: challenges and potential.

    Beverly A. Teicher;Ravi V.J. Chari

  • Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

    Beverly A. Teicher;Terence S. Herman;Sylvia A. Holden;Yenyun Wang

  • The hypoxic tumor cell: a target for selective cancer chemotherapy.

    Katherine A. Kennedy;Beverly A. Teicher;Sara Rockwell;Alan C. Sartorelli

  • Acquired multicellular-mediated resistance to alkylating agents in cancer.

    Hiroaki Kobayashi;Shan Man;Charles H. Graham;Sean J. Kapitain

  • Characterization of a Human Squamous Carcinoma Cell Line Resistant to cis-Diamminedichloroplatinum(II)

    Beverly A. Teicher;Sylvia A. Holden;Michael J. Kelley;Thomas C. Shea

  • Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.

    Beverly A. Teicher;Sylvia A. Holden;Gulshan Ara;Enrique Alvarez Sotomayor

  • Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.

    Beverly A. Teicher;Enrique Alvarez Sotomayor;Zhen Dong Huang

  • Comprehensive characterization of the Published Kinase Inhibitor Set

    Jonathan M. Elkins;Vita Fedele;Marta Szklarz;Kamal R. Abdul Azeez

  • Perfluorochemical emulsions can increase tumor radiosensitivity

    Beverly A. Teicher;Christopher M. Rose

  • PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.

    Benjamin H. Lok;Eric E. Gardner;Eric E. Gardner;Valentina E. Schneeberger;Andy Ni

  • Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.

    Beverly A. Teicher;Sylvia A. Holden;Antoine Al-Achi;Terence S. Herman

Frequent Co-Authors

Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
James H. Doroshow
James H. Doroshow National Institutes of Health
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Yves Pommier
Yves Pommier National Institutes of Health
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
Yael P. Mosse
Yael P. Mosse Children's Hospital of Philadelphia
Katherine W. Klinger
Katherine W. Klinger Sanofi (United States)
William C. Reinhold
William C. Reinhold National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending a traditional, on-campus program. Today, more students are taking advantage of flexible options such as cheapest online fnp program pathways, which allow aspiring nurse practitioners to earn credentials affordably and conveniently.

For those just beginning their journey, nursing school online opens doors to entry-level and advanced nursing roles while balancing other life commitments. Registered nurses seeking advancement can benefit from cheap rn to bsn online programs that deliver quality instruction without the high cost or need to relocate.

Professionals interested in research or academic positions can consider pursuing an online phd in nursing, which provides the flexibility to conduct research and further knowledge while managing work responsibilities.

These affordable online degree choices broaden access to rewarding healthcare careers, supporting students at every stage—whether starting out, advancing, or specializing within the field of medicine.

Best Scientists Citing Beverly A. Teicher

Trending Scientists

Recently Published Articles